- Home
- FRSH vs VCYT Comparison
FRSH vs VCYT Comparison
Compare FRSH & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRSH | VCYT |
|---|---|---|
| Founded | 2010 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.8B |
| IPO Year | 2021 | 2013 |
Fundamental Metrics
Financial Performance| Metric | FRSH | VCYT |
|---|---|---|
| Price | $8.30 | $35.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 8 |
| Target Price | $14.86 | ★ $46.50 |
| AVG Volume (30 Days) | ★ 7.6M | 799.8K |
| Earning Date | 05-12-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 296.88 | 164.52 |
| EPS | 0.63 | ★ 0.82 |
| Revenue | ★ $838,809,000.00 | N/A |
| Revenue This Year | $16.17 | $11.95 |
| Revenue Next Year | $14.32 | $11.97 |
| P/E Ratio | ★ $12.79 | $44.06 |
| Revenue Growth | ★ 16.43 | N/A |
| 52 Week Low | $6.79 | $22.61 |
| 52 Week High | $16.81 | $50.71 |
Technical Indicators
Market Signals| Indicator | FRSH | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 45.01 | 42.34 |
| Support Level | $6.80 | $35.02 |
| Resistance Level | $12.30 | $37.24 |
| Average True Range (ATR) | 0.46 | 1.56 |
| MACD | 0.21 | 0.24 |
| Stochastic Oscillator | 89.94 | 26.80 |
Price Performance
Historical ComparisonAbout FRSH Freshworks Inc.
Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.